Twentyeight-Seven Therapeutics launches to boost anticancer microRNA with small-molecule drugs
Wednesday, September 12, 2018 - 16:30
in Biology & Nature
With $65 million raised, 28-7 is developing inhibitors of the Lin28 protein to boost levels of an anticancer microRNA called let-7